{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=HTN&page=98", "query": { "condition": "HTN", "page": 98 }, "page_size": 10 }, "pagination": { "page": 98, "page_size": 10, "total_count": 3925, "total_pages": 393, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=HTN&page=99&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=HTN&page=97&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-11T12:02:05.283Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04452331", "title": "Assessing Open Access Audio", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertension", "Diabetes" ], "interventions": [ { "name": "Open Access Audio", "type": "OTHER" }, { "name": "No Access, Patient and Provider Aware of Recording", "type": "OTHER" }, { "name": "No Access, Provider Unaware of Recording", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1553, "start_date": "2021-10-05", "completion_date": "2024-07-31", "has_results": true, "last_update_posted_date": "2025-04-03", "last_synced_at": "2026-11-11T12:02:05.283Z", "location_count": 2, "location_summary": "Chicago, Illinois • Cleveland, Ohio", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04452331" }, { "nct_id": "NCT07354477", "title": "Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-proliferative Diabetic Retinopathy (NPDR)", "Open-angle Glaucoma (OAG)", "Normal Tension Glaucoma (NTG)" ], "interventions": [ { "name": "QLS-111 Ophthalmic Solution (0.015%)", "type": "DRUG" }, { "name": "QLS-111 Ophthalmic Solution (0.075%)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Qlaris Bio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9, "start_date": "2026-02-20", "completion_date": "2026-10-01", "has_results": false, "last_update_posted_date": "2026-11-02", "last_synced_at": "2026-11-11T12:02:05.283Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07354477" }, { "nct_id": "NCT05144737", "title": "A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus", "Diabetes Mellitus, Type 2", "PreDiabetes", "Hypertension", "High Blood Pressure", "High Blood Sugar", "Obesity", "Overweight", "Overweight and Obesity", "Overweight or Obesity" ], "interventions": [ { "name": "The Diabetes Prevention Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "25 Years to 75 Years" }, "enrollment_count": 60, "start_date": "2021-11-21", "completion_date": "2024-08-16", "has_results": true, "last_update_posted_date": "2026-04-23", "last_synced_at": "2026-11-11T12:02:05.283Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05144737" }, { "nct_id": "NCT03216902", "title": "A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Open-angle Glaucoma, Ocular Hypertension" ], "interventions": [ { "name": "Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution", "type": "DRUG" }, { "name": "Topical ultra-low dose of DE-126 Ophthalmic Solution", "type": "DRUG" }, { "name": "Topical low dose of DE-126 Ophthalmic Solution", "type": "DRUG" }, { "name": "Topical medium dose of DE-126 Ophthalmic Solution", "type": "DRUG" }, { "name": "Topical high dose of DE-126 Ophthalmic Solution", "type": "DRUG" }, { "name": "0.005% Latanoprost Ophthalmic Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Santen Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 241, "start_date": "2017-07-25", "completion_date": "2018-02-27", "has_results": true, "last_update_posted_date": "2020-10-23", "last_synced_at": "2026-11-11T12:02:05.283Z", "location_count": 12, "location_summary": "Artesia, California • Mission Hills, California • Newport Beach, California + 9 more", "locations": [ { "city": "Artesia", "state": "California" }, { "city": "Mission Hills", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Petaluma", "state": "California" }, { "city": "Largo", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03216902" }, { "nct_id": "NCT01658657", "title": "A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertension", "Plasma Renin Activity" ], "interventions": [ { "name": "Hydrochlorothiazide", "type": "DRUG" }, { "name": "Lisinopril", "type": "DRUG" }, { "name": "Amlodipine", "type": "DRUG" }, { "name": "metoprolol", "type": "DRUG" }, { "name": "lisinopril/hydrochlorothiazide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2012-10", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2015-08-27", "last_synced_at": "2026-11-11T12:02:05.283Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01658657" }, { "nct_id": "NCT00302718", "title": "Financial Incentives to Translate ALLHAT Into Practice: A Randomized Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Physician-level financial incentives", "type": "BEHAVIORAL" }, { "name": "Practice-level financial incentives", "type": "BEHAVIORAL" }, { "name": "Physician- and practice-level financial incentives", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 83, "start_date": "2007-02", "completion_date": "2012-09", "has_results": true, "last_update_posted_date": "2019-01-30", "last_synced_at": "2026-11-11T12:02:05.283Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Newington, Connecticut • Augusta, Georgia + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Newington", "state": "Connecticut" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00302718" }, { "nct_id": "NCT06135727", "title": "Screening Protocol", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Glaucoma" ], "interventions": [ { "name": "Maestro2 OCT", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Topcon Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 26, "start_date": "2023-11-07", "completion_date": "2024-08-02", "has_results": false, "last_update_posted_date": "2025-09-10", "last_synced_at": "2026-11-11T12:02:05.283Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06135727" }, { "nct_id": "NCT01371890", "title": "Mechanisms and Treatment of Intradialytic Hypertension - Sodium", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hemodialysis", "End-stage Renal Disease", "Hypertension", "Intradialytic Hypertension" ], "interventions": [], "intervention_types": [], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 18, "start_date": "2011-05", "completion_date": "2012-08", "has_results": false, "last_update_posted_date": "2020-12-21", "last_synced_at": "2026-11-11T12:02:05.283Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01371890" }, { "nct_id": "NCT06907524", "title": "Preventative Screening and Health Coaching in a Food Insecure Population", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cardiovascular Disease Prevention", "Cardiometabolic Diseases", "Cardiovascular Risk Factor", "Cardiovascular Risk Score", "Hypertension", "Hyperlipidemia", "Diabetes", "Lifestyle Modification", "Health Coaching" ], "interventions": [ { "name": "Longitudinal, Individualized Health Coaching", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Rush University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 200, "start_date": "2025-03-01", "completion_date": "2027-07-01", "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-11-11T12:02:05.283Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06907524" }, { "nct_id": "NCT04592380", "title": "Clevidipine vs Placebo or Standard of Care for Dyspnea and Blood Pressure Control in AHF", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dyspnea", "Hypertension", "Acute Heart Failure" ], "interventions": [ { "name": "Stage 1: Clevidipine (double-blinded)", "type": "DRUG" }, { "name": "Stage 1: Placebo (double-blinded)", "type": "DRUG" }, { "name": "Stage 2: Clevidipine (open-label)", "type": "DRUG" }, { "name": "Stage 2: Standard of Care (open-label)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Medicines Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2014-08", "completion_date": "2016-11", "has_results": false, "last_update_posted_date": "2020-10-19", "last_synced_at": "2026-11-11T12:02:05.283Z", "location_count": 9, "location_summary": "Montgomery, Alabama • Tucson, Arizona • St Louis, Missouri + 5 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Brooklyn", "state": "New York" }, { "city": "Brooklyn", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04592380" } ] }